Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -27.92% | -62.93% |
Apr. 11 | Syncona to Sell Stake in Portfolio Company to Century Therapeutics | MT |
Feb. 20 | Syncona’s Takeover of Freeline Therapeutics Becomes Effective | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter McCormack
DFI | Director of Finance/CFO | 45 | 09-12-31 |
Bruce Jackson
CTO | Chief Tech/Sci/R&D Officer | 55 | 13-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Leonardo de Luca
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 149,719,272 | 71,715,197 ( 47.90 %) | 0 | 47.90 % |
Company contact information
1st Jan change | Capi. | |
---|---|---|
-62.93% | 0 | |
+5.58% | 80.86B | |
+3.69% | 75.4B | |
-14.62% | 52.54B | |
-24.56% | 51.47B | |
+31.16% | 48.04B | |
+17.75% | 40.73B | |
+55.21% | 35.61B | |
-10.24% | 24.47B | |
-21.24% | 22.73B |
- Stock Market
- Equities
- MYRN Stock
- Company Myriad Group AG